(Q33179595)

23 July 2017

1 reference

title

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia (English)

1 reference

23 July 2017

0 references

0 references

Fenton WS

1

1 reference

23 July 2017

Hibbeln J

series ordinal

2

1 reference

23 July 2017

Knable M

series ordinal

3

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

23 July 2017

published in

Biological Psychiatry

1 reference

23 July 2017

volume

47

1 reference

23 July 2017

issue

1

1 reference

23 July 2017

page(s)

8-21

1 reference

Effect of ADP on PGE1Formation in Blood Platelets from Patients with Depression, Mania and Schizophrenia

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Fat consumption and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Evaluation of treatment-resistant schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Schizophrenic patients treated with high dose phenothiazine or thioxanthene become deficient in polyunsaturated fatty acids in their thrombocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Correlation between acetylcholine receptor function and structural properties of membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Phospholipase A2 and the hypofrontality hypothesis of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Increased platelet phospholipase A2 activity in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Membrane fatty acids, niacin flushing and clinical parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Synaptic elimination, neurodevelopment, and the mechanism of hallucinated "voices" in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Schizophrenia as a prostaglandin deficiency disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Prostaglandins and schizophrenia: further discussion of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Fatty acid levels in the brains of schizophrenics and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Essential fatty acids in plasma phospholipids in schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Genetic variant near cytosolic phospholipase A2 associated with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Phospholipases: in search of a genetic base of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Elevated plasma prostaglandin E2 levels in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Erythrocyte membrane phospholipids in psychotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Formation of 15-lipoxygenase product from docosahexaenoic acid (22:6w3) by human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Vocational rehabilitation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

The niacin challenge test in schizophrenia: past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Schizophrenia and intercurrent physical illness: A critical review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Free radical pathology and antioxidant defense in schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Occurrence of painless acute surgical disorders in psychotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

The Nithsdale Schizophrenia Surveys. 16. Breast-feeding and schizophrenia: preliminary results and hypotheses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Schizophrenic symptoms and dietary intake of n-3 fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Absence of Rheumatoid Arthritis in Schizophrenia*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Potentiation of NMDA receptor currents by arachidonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Elevated PLA2 activity in schizophrenics and other psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Fatty acid profiles in mental disease. Part 1. Linolenate variations in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Arachidonic Acid: A Common Link in the Biology of Schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Ingestion of fish oil or a derived n-3 fatty acid concentrate containing eicosapentaenoic acid (EPA) affects fatty acid compositions of individual phospholipids of rat brain, sciatic nerve and retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment With Eicosapentaenoic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Polydipsia in rhesus monkeys deficient in omega-3 fatty acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Niacin test in schizophrenia and affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

The nervous system has an absolute molecular species requirement for proper function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Lipoxygenation of docosahexaenoic acid by the rat pineal body.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Dyskinesias and their treatment with essential fatty acids: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Penicillin and essential fatty acid supplementation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Schizophrenia, tardive dyskinesia and essential fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Negative association between schizophrenia and rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Do essential fatty acids play a role in brain and behavioral development?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Niacin skin flush in schizophrenia: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Niacin skin flush is not diagnostic of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Characterization of the influence of unsaturated free fatty acids on brain GABA/benzodiazepine receptor binding in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Essential fatty acid supplementation in tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Increasing fish oil intake--any net benefits?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

Are omega 3 fatty acids essential nutrients for mammals?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900092-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00092-X

1 reference

23 July 2017

1 reference